Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed -18.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Debt / revenue changed +13235 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +261 basis points from the comparable as-filed period.
Current ratio changed -12.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Revenue changed +14.5% from the comparable as-filed period.
Selling, general & administrative changed +20.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed +60.3% from the comparable as-filed period.
Operating cash flow changed +8.2% from the comparable as-filed period.
Capex / revenue changed -83 basis points from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Stock-based compensation changed +11.8% from the comparable as-filed period.
Research & development changed +2.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -8.1% from the comparable as-filed period.
SBC / revenue changed -2 basis points from the comparable as-filed period.
R&D / revenue changed -21 basis points from the comparable as-filed period.
Operating cash-flow margin changed -73 basis points from the comparable as-filed period.
Free-cash-flow margin changed +10 basis points from the comparable as-filed period.
Debt / revenue changed +14322 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +1248 basis points from the comparable as-filed period.
Operating cash flow / net income changed +171.5% from the comparable as-filed period.
Operating cash-flow margin changed +1257 basis points from the comparable as-filed period.
Revenue changed -2.4% from the comparable as-filed period.
Inventory changed -2.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -11.2% from the comparable as-filed period.
Capex / revenue changed +9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -2.9% from the comparable as-filed period.
Shares outstanding changed +0.7% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Inventory / revenue changed -29 basis points from the comparable as-filed period.
SBC / revenue changed +9 basis points from the comparable as-filed period.
Stock-based compensation changed +9.6% from the comparable as-filed period.
Selling, general & administrative changed +0.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -21 basis points from the comparable as-filed period.
Capital expenditure changed -0.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.